Shanghai, China

Baoli Li

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: East China University of Science and Technology. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Baoli Li. Retrieved from https://idiyas.com/inventor/baoli-li-zi2m20mn

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Baoli Li: Innovator in Antibacterial Drug Development

Introduction

Baoli Li is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of antibacterial agents. His innovative work has led to the creation of a patent that addresses critical health challenges.

Latest Patents

Baoli Li holds a patent for "Benzoheterocyclic alkylamine compounds and use thereof." This patent discloses benzoheterocyclic alkylamine compounds, or a pharmaceutically acceptable salt thereof, or a stereoisomer thereof. It also details a preparation method and the use of these compounds in the manufacture of an antibacterial drug as an inhibitor of staphyloxanthin synthesis.

Career Highlights

Throughout his career, Baoli Li has worked with esteemed institutions such as East China University of Science and Technology and the Chinese Academy of Sciences. His research has focused on developing novel compounds that can combat bacterial infections effectively.

Collaborations

Baoli Li has collaborated with notable colleagues, including Feifei Chen and Lefu Lan. These partnerships have enhanced his research and contributed to the advancement of antibacterial drug development.

Conclusion

Baoli Li's innovative work in the field of medicinal chemistry has led to significant advancements in antibacterial drug development. His contributions are vital in addressing the growing challenge of antibiotic resistance.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…